This slideshow reviews drug information for DARZALEX (daratumumab), indicated for multiple myeloma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 16: Use in Specific PopulationsSlide 19: Clinical PharmacologySlide 23: Warnings and PrecautionsSlide 28: Clinical Safety and EfficacySlide 46: Drug Storage and SupplySlide 49: References
This slideshow reviews drug information for KEYTRUDA (pembrolizumab), indicated for non-small cell lung cancer. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 11: Use in Specific PopulationsSlide 14: Clinical PharmacologySlide 18: Warnings and PrecautionsSlide 24: Clinical Safety and EfficacySlide 41: Drug Storage and SupplySlide 43: References
This slideshow reviews drug information for KEYTRUDA (pembrolizumab), indicated for head and neck cancer. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 10: Use in Specific PopulationsSlide 13: Clinical PharmacologySlide 17: Warnings and PrecautionsSlide 22: Clinical Safety and EfficacySlide 28: Drug Storage and SupplySlide 30: References
This slideshow reviews drug information for NINLARO (ixazomib), indicated for multiple myeloma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 9: Use in Specific PopulationsSlide 12: Clinical PharmacologySlide 16: Warnings and PrecautionsSlide 22: Clinical Safety and EfficacySlide 28: Drug Storage and SupplySlide 30: References
This slideshow reviews drug information for VENCLEXTA (venetoclax), indicated for chronic lymphocytic leukemia. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 14: Use in Specific PopulationsSlide 17: Clinical PharmacologySlide 23: Warnings and PrecautionsSlide 19: Clinical Safety and EfficacySlide 27: Drug Storage and SupplySlide 33: References
This slideshow reviews drug information for SUTENT (sunitinib), indicated for gastrointestinal stream tumors (GISTs), advanced renal cell carcinoma (RCC), and pancreatic neuroendocrine tumors (pNETs). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 7: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 19: Clinical Safety and EfficacySlide 33: Drug Storage and SupplySlide…
This slideshow reviews drug information for TAGRISSO (osimertinib), indicated for metastatic non-small cell lung cancer (NSCLC). Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 8: Use in Specific PopulationsSlide 11: Clinical PharmacologySlide 16: Warnings and PrecautionsSlide 20: Clinical Safety and EfficacySlide 26: Drug Storage and SupplySlide 28: References
This slideshow reviews drug information for INTRON A (interferon alfa-2b), indicated for malignant melanoma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 10: Use in Specific PopulationsSlide 13: Clinical PharmacologySlide 17: Warnings and PrecautionsSlide 22: Clinical Safety and EfficacySlide 29: Drug Storage and SupplySlide 31: References
This slideshow reviews drug information for PORTRAZZA (necitumumab), indicated for metastatic squamous non-small cell lung cancer. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 9: Use in Specific PopulationsSlide 11: Clinical PharmacologySlide 15: Warnings and PrecautionsSlide 20: Clinical Safety and EfficacySlide 26: Drug Storage and SupplySlide 28: References
This slideshow reviews drug information for ALECENSA (alectinib), indicated for metastatic non-small cell lung cancer.Table of ContentsSlide 3: Indication, Dosage, and AdministrationSlide 10: Use in Specific PopulationsSlide 13: Clinical PharmacologySlide 17: Warnings and PrecautionsSlide 22: Clinical Safety and EfficacySlide 29: Drug Storage and SupplySlide 31: References
Please login or register first to view this content.
